Background The emergence of SARS-CoV-2 has led to the development of serological
assays that could aid in an understanding of the burden of COVID-19 disease. Many available …

Background Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been shown to neutralize the virus in vitro and prevent disease in animal challenge …

Introduction Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) specific
antibodies have been shown to neutralize the virus in-vitro. Understanding antibody dynamics …

Human infection challenge permits in-depth, early, and pre-symptomatic characterization of
the immune response, enabling the identification of factors that are important for viral …

Sensitive serological testing is essential to estimate the proportion of the population exposed
or infected with SARS-CoV-2, to guide booster vaccination and to select patients for …

Background Antibody Fc-mediated functions, such as antibody-dependent cellular cytotoxicity,
contribute to vaccine-induced protection against viral infections. Fc-mediated function of …

BACKGROUND NK cells are activated by innate cytokines and viral ligands to kill virus-infected
cells. These functions are enhanced during secondary immune responses and after …

The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the
cellular disease dynamics remains limited. In our unique COVID-19 human challenge study we …

Natural killer (NK) cells are implicated among immune effectors after vaccination against viral
pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen…

Vaccination has proved to be highly effective in reducing global mortality and eliminating
infectious diseases. Building on this success will depend on the development of new and …